Sequent Scientific - Viyash Scientific Share Price

Overview
Recos
News
Analysis
Financials
Forecast
Technicals
Peers
Shareholdings
MF
F&O
Corp Actions
About

Sequent Scientific - Viyash Scientific Share Price

252.30-5.10 (-1.99%)

Closed
As On: 10 Jun, 2026, 03:58 PM IST
As On: 10 Jun, 2026, 03:40 PM IST

Sector: Pharmaceuticals
Industry: Pharma - Indian

Open	259.95
High	263.70
Low	251.05
Prev Close	257.40
Volume	18,17,257
VWAP(₹)	258.09

Key Metrics

PE Ratio(x)	92.16
EPS - TTM(₹)	2.74
MCap(₹ Cr.)	11,021.75
MCap Rank	43
PB Ratio(x)	3.61
Div Yield(%)	-
Face Value(₹)	2.00
52W High(₹)	277.35
52W Low(₹)	166.00
MCap/Sales	2.34
Beta(1 Month)	1.03
BV/Share(₹)	71.30

Sequent Scientific share price insights

Beating 3 Yr Revenue CAGR
Company's annual revenue growth of 121.18% outperformed its 3 year CAGR of 33.99%. (Source: Consolidated Financials)
Employee & Interest Expense
Company has spent 2.02% of its operating revenues towards interest expenses and 16.53% towards employee cost in the year ending Mar 31, 2026. (Source: Consolidated Financials)
Sequent Scientific Share Price Update
Viyash Scientific Ltd. share price moved down by -1.99% from its previous close of Rs 257.40. Viyash Scientific Ltd. stock last traded price is 252.30
Share Price Value
Today/Current/Last 252.30254.30
Previous Day 257.40257.30

Share Price	Value
Today/Current/Last	252.30254.30
Previous Day	257.40257.30

Found Insights useful?

Sequent Scientific Share Price Returns

1 Day	-1.99%
1 Month	14.89%
3 Months	27.78%
1 Year	33.42%
3 Years	231.1%
5 Years	-7.43%

Sequent Scientific Share Recommendations

Mean recosCurrent

STRONG BUY

2 Analysts

Strong
SellSellHoldBuyStrong
Buy

Analyst Trends

Ratings	Current	1W Ago	1M Ago	3M Ago
Strong Buy	2	2	1	-
Buy	-	-	-	-
Hold	-	-	-	-
Sell	-	-	-	-
Strong Sell	-	-	-	-
# Analysts	2	2	1	-

Recent Recos

Target₹130
OrganizationYes Securities
BUY

Target₹145
OrganizationHDFC Securities
BUY

Target₹285
OrganizationMotilal Oswal Financial Services
BUY

View all Stock Recommendations

News & Analysis

Carlyle-backed Viyash Scientific buys Italy’s BioForLife for Rs 188 crore
News
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Announcements
Announcement under Regulation 30 (LODR)-Acquisition
Announcements
Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
Announcements

View all Sequent Scientific Share News & Announcements

Share Analysis

EARNINGS

FUNDAMENTAL

RELATIVE VALUATION

RISK

PRICE MOMENTUM

Unlock Stock Score, Analyst' Ratings & Recommendations

Score on 10-point scale
Ratings by analysts
Stock performance

JOIN ET PRIME

Financials

Income (P&L)

	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024
Total Income	872.39	426.14	445.29	403.36	396.65
Total Income Growth (%)	104.72	-4.30	10.40	1.69	6.29
Total Expenses	782.57	385.47	405.61	371.92	373.60
Total Expenses Growth (%)	103.02	-4.97	9.06	-0.45	6.45
EBIT	89.82	40.67	39.68	31.44	23.05
EBIT Growth (%)	120.85	2.49	26.21	36.40	3.88
Profit after Tax (PAT)	38.44	14.74	14.31	9.32	6.48
PAT Growth (%)	160.79	3.00	53.54	43.83	2.21
EBIT Margin (%)	10.30	9.54	8.91	7.79	5.81
Net Profit Margin (%)	4.41	3.46	3.21	2.31	1.63
Basic EPS (₹)	0.89	0.59	0.57	0.37	0.14

	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024
Total Income	357.93	45.78	52.55	54.60	48.15
Total Income Growth (%)	681.85	-12.88	-3.75	13.40	-16.90
Total Expenses	343.76	40.61	46.69	47.70	43.30
Total Expenses Growth (%)	746.49	-13.02	-2.12	10.16	-14.31
EBIT	14.17	5.17	5.86	6.90	4.85
EBIT Growth (%)	174.08	-11.77	-15.07	42.27	-34.55
Profit after Tax (PAT)	-0.08	3.08	3.37	4.23	2.81
PAT Growth (%)	-102.60	-8.61	-20.33	50.53	-34.04
EBIT Margin (%)	3.96	11.29	11.15	12.64	10.07
Net Profit Margin (%)	-0.02	6.73	6.41	7.75	5.84
Basic EPS (₹)	0.00	0.12	0.14	0.17	0.11

	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	1,566.06	1,380.69	1,427.30	1,423.66	1,369.98
Total Revenue Growth (%)	13.43	-3.27	0.26	3.92	15.19
Total Expenses	1,516.77	1,417.94	1,500.16	1,370.28	1,224.53
Total Expenses Growth (%)	6.97	-5.48	9.48	11.90	11.80
Profit after Tax (PAT)	21.88	-35.87	-121.16	41.25	95.44
PAT Growth (%)	-	-	-393.71	-56.78	36.53
Operating Profit Margin (%)	7.09	0.79	-2.62	4.89	12.47
Net Profit Margin (%)	1.41	-2.61	-8.52	2.91	7.00
Basic EPS (₹)	0.88	-1.44	-4.88	1.67	3.87

	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	229.19	214.50	250.93	247.27	285.42
Total Revenue Growth (%)	6.85	-14.52	1.48	-13.37	18.00
Total Expenses	202.27	208.48	260.67	231.58	241.98
Total Expenses Growth (%)	-2.98	-20.02	12.56	-4.30	10.45
Profit after Tax (PAT)	15.79	0.62	-6.08	14.80	32.11
PAT Growth (%)	2,439.23	-	-141.08	-53.92	50.48
Operating Profit Margin (%)	17.32	6.15	-3.24	7.87	17.37
Net Profit Margin (%)	8.86	0.36	-2.73	6.73	12.09
Basic EPS (₹)	0.63	0.03	-0.24	0.60	1.30

All figures in Rs Cr, unless mentioned otherwise

Insights

Beating 3 Yr Revenue CAGR
Company's annual revenue growth of 121.18% outperformed its 3 year CAGR of 33.99%. (Source: Consolidated Financials)
Employee & Interest Expense
Company has spent 2.02% of its operating revenues towards interest expenses and 16.53% towards employee cost in the year ending Mar 31, 2026. (Source: Consolidated Financials)

View Details

Balance Sheet

Annual	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Assets	1,601.95	1,540.38	1,529.12	1,441.50	1,392.56
Total Assets Growth (%)	4.00	0.74	6.08	3.51	-8.28
Total Liabilities	831.58	827.43	779.93	701.08	616.24
Total Liabilities Growth (%)	0.50	6.09	11.25	13.77	-15.68
Total Equity	770.36	712.96	749.19	740.41	776.32
Total Equity Growth (%)	8.05	-4.84	1.19	-4.62	-1.42
Current Ratio (x)	1.73	1.31	1.50	1.54	1.55
Total Debt to Equity (x)	0.63	0.69	0.57	0.46	0.27
Contingent Liabilities	559.95	588.21	184.31	223.52	6.26

Annual	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Assets	1,222.20	1,187.60	1,122.77	1,124.23	1,102.12
Total Assets Growth (%)	2.91	5.77	-0.13	2.01	10.50
Total Liabilities	79.55	100.37	64.41	83.14	72.61
Total Liabilities Growth (%)	-20.74	55.83	-22.53	14.50	-34.67
Total Equity	1,142.65	1,087.23	1,058.36	1,041.09	1,029.51
Total Equity Growth (%)	5.10	2.73	1.66	1.12	16.17
Current Ratio (x)	1.42	1.07	1.38	1.81	1.69
Total Debt to Equity (x)	0.04	0.04	0.02	0.02	0.01
Contingent Liabilities	515.57	284.45	266.31	247.44	0.99

All figures in Rs Cr, unless mentioned otherwise

View Details

Cash Flows

Annual	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash flow from Operating Activities	83.36	30.60	16.81	30.60	114.75
Net Cash used in Investing Activities	-24.78	-5.92	-64.96	-95.57	9.65
Net Cash flow from Financing Activities	-60.73	-1.44	32.23	67.26	-138.75
Net Cash Flow	-2.15	23.24	-15.92	3.75	-14.35
Closing Cash & Cash Equivalent	62.66	64.81	41.57	57.50	53.74
Closing Cash & Cash Equivalent Growth (%)	-3.32	55.89	-27.69	6.98	-21.08
Total Debt/ CFO (x)	5.35	14.75	23.67	10.29	1.71

Annual	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash flow from Operating Activities	-1.13	-26.94	37.75	9.36	2.34
Net Cash used in Investing Activities	-0.44	5.47	-50.70	-4.25	170.00
Net Cash flow from Financing Activities	0.67	22.32	0.24	7.25	-174.78
Net Cash Flow	-0.90	0.84	-12.71	12.36	-2.44
Closing Cash & Cash Equivalent	0.03	0.93	0.08	12.80	0.44
Closing Cash & Cash Equivalent Growth (%)	-96.76	1,015.66	-99.35	2,841.61	-84.86
Total Debt/ CFO (x)	-39.45	-1.72	0.51	1.66	2.23

All figures in Rs Cr, unless mentioned otherwise

Insights

Increase in Cash from Investing
Company has used Rs 84.12 cr for investing activities which is an YoY increase of 239.49%. (Source: Consolidated Financials)

View Details

Ratios

Annual	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Return on Equity (%)	3.10	-5.46	-17.33	6.03	13.11
Return on Capital Employed (%)	10.03	1.18	-3.72	7.44	18.22
Return on Assets (%)	1.36	-2.32	-7.92	2.86	6.85
Interest Coverage Ratio (x)	2.91	1.51	0.52	7.62	6.97
Asset Turnover Ratio (x)	0.99	0.89	0.17	0.17	97.77
Price to Earnings (x)	151.52	-80.65	-14.95	80.65	62.89
Price to Book (x)	4.65	4.38	2.59	4.86	8.22
EV/EBITDA (x)	21.06	45.79	120.86	30.16	28.00
EBITDA Margin (%)	11.37	5.28	1.29	8.51	16.18

Annual	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Return on Equity (%)	1.38	0.05	-0.57	1.43	3.11
Return on Capital Employed (%)	2.69	0.95	-0.68	1.65	4.47
Return on Assets (%)	1.29	0.05	-0.54	1.31	2.91
Interest Coverage Ratio (x)	9.99	4.43	0.75	16.70	17.21
Asset Turnover Ratio (x)	0.15	0.15	0.20	0.20	24.08
Price to Earnings (x)	208.33	5,000.00	-303.03	227.27	188.68
Price to Book (x)	2.87	2.65	1.71	3.22	5.81
EV/EBITDA (x)	83.88	151.24	972.14	123.67	108.36
EBITDA Margin (%)	22.18	11.46	0.84	12.24	20.81

Found Financials useful?

Share Price Forecast

Exclusively for ETPrime

REVENUE
Invest in the Best
Check two-year estimates on Price, Revenue & Earnings
READ FOR FREE ON APP
EARNINGS
Invest in the Best
Check two-year estimates on Price, Revenue & Earnings
READ FOR FREE ON APP
PRICE
Invest in the Best
Check two-year estimates on Price, Revenue & Earnings
READ FOR FREE ON APP

Technicals

Buy/Sell Signals
No Data Available
Price Analysis
No Data Available
Pivot Levels
R1 - Pivot
-
S1 -
R2 - S2 -
R3 - S3 -
Average True Range
5 Days 14 Days 28 Days
- - -

5 Days	14 Days	28 Days
-	-	-

Peer Comparison

Ratio Performance

NAME	P/E (x)	P/B (x)	ROE %	ROCE %	ROA %	Rev CAGR [3Yr]	OPM	NPM	Basic EPS	Current Ratio	Total Debt/ Equity (x)	Total Debt/ CFO (x)
Sequent Scientific	92.16	3.54	6.08	12.55	3.83	33.99	13.52	6.56	4.09	2.38	0.15	1.35
Supriya Lifescience	36.65	6.40	17.45	22.42	15.40	21.05	33.47	25.25	25.98	4.40	0.00	0.00
Suven Life Sci	-25.65	11.98	-46.72	-46.54	-44.27	-1.44	-3,881.91	-3,884.12	-12.13	17.69	0.00	0.00
Sun Pharma Adv Res.	4.30	4.99	116.01	112.89	71.54	95.04	85.11	82.65	47.86	2.47	0.42	-2.33
Innova Captab	36.96	4.77	12.91	15.27	7.66	20.29	12.58	8.64	24.63	1.87	0.31	2.94
Add More

Annual Ratios (%)

Choose from Peers

Orchid Pharma
Zota Healthcare
Gujarat Themis
RPG Life Sci
Aarti Drugs

Choose from Stocks

Stock Performance

CHART
TABLE

Choose from Peers
Choose from Stocks

NAME	1D	1W	1M	3M	1Y	3Y	5Y
Sequent Scientific Stock Performance	-1.99	9.48	21.27	16.40	41.16	222.22	-7.55
Supriya Lifescience Stock Performance	-1.10	38.99	53.43	40.48	33.07	292.82	0.00
Suven Life Sci Stock Performance	1.65	30.14	27.70	77.92	26.93	372.41	178.69
Sun Pharma Adv Res. Stock Performance	-1.57	21.07	42.95	59.37	24.21	5.93	-8.24
Innova Captab Stock Performance	-0.51	4.38	25.77	35.94	3.12	0.00	0.00
Add More

Shareholding Pattern

Total Shareholdings
Category No. of Shares Percentage % Change QoQ
Promoters 26,78,40,334 61.31 % -0.09
Pledge 0 0.00 % 0.00
FII 1,28,50,145 2.94 % -0.21
DII 3,48,88,566 7.98 % 0.62
MF 2,81,51,632 6.44 % 0.62
Others 12,12,71,765 27.76 % -0.31
QoQ Change
Category Mar 2026 Dec 2025 Sep 2025 Jun 2025
Promoters 61.31 61.41 52.33 52.61
Pledge 0.00 0.00 0.00 0.00
FII 2.94 3.15 5.90 6.15
DII 7.98 7.36 12.91 12.98
Mutual Funds 6.44 5.82 10.04 10.08
Others 27.76 28.08 28.86 28.26

Category	No. of Shares	Percentage	% Change QoQ
Promoters	26,78,40,334	61.31 %	-0.09
Pledge	0	0.00 %	0.00
FII	1,28,50,145	2.94 %	-0.21
DII	3,48,88,566	7.98 %	0.62
MF	2,81,51,632	6.44 %	0.62
Others	12,12,71,765	27.76 %	-0.31

Category	Mar 2026	Dec 2025	Sep 2025	Jun 2025
Promoters	61.31	61.41	52.33	52.61
Pledge	0.00	0.00	0.00	0.00
FII	2.94	3.15	5.90	6.15
DII	7.98	7.36	12.91	12.98
Mutual Funds	6.44	5.82	10.04	10.08
Others	27.76	28.08	28.86	28.26

Mutual Funds Ownership

MF Ownership as on 30 April 2026

Quant Small Cap Direct-G
Equity: Small Cap
3
- 488.82
  Amount Invested (in Cr.)
- 1.609354%
  % of AUM
- 0.00
  % Change (MoM basis)
Quant Healthcare Direct-G
Equity: Sectoral-Pharma
- 30.32
  Amount Invested (in Cr.)
- 8.615217%
  % of AUM
- 0.00
  % Change (MoM basis)
UTI Healthcare Direct-G
Equity: Sectoral-Pharma
4
- 22.34
  Amount Invested (in Cr.)
- 1.95350545%
  % of AUM
- -0.03
  % Change (MoM basis)

View all Mutual Fund Schemes

Sequent Scientific Top Searches

Corporate Actions

Recent
General Meeting
-
Jun 01, 2026
Board Meeting
Audited Results & Final Dividend
May 12, 2026
General Meeting
-
Feb 10, 2026

Board Meetings

Announced on	Meeting on
May 12, 2026	May 19, 2026
Audited Results & Final Dividend
Jan 21, 2026	Feb 05, 2026
Quarterly Results
Nov 03, 2025	Nov 14, 2025
Quarterly Results
Jul 31, 2025	Aug 08, 2025
Quarterly Results
May 08, 2025	May 20, 2025
Audited Results & Final Dividend

Dividends
Announced on Ex-Date Dividend%
Jul 01, 2021 Sep 08, 2021 25%
May 14, 2019 Aug 21, 2019 10%
Nov 09, 2017 Nov 20, 2017 10%
May 30, 2011 Sep 16, 2011 15%
May 31, 2010 Sep 23, 2010 20%
Bonus
No Data Available
Splits
Announced on Ex-Date
Oct 29, 2015 Feb 25, 2016
Split: Old FV10.0| New FV:2.0
Rights
No Data Available
AGM/EGM Meetings
Announced on Meeting on
Jun 01, 2026 Jun 30, 2026
-
Feb 10, 2026 Mar 14, 2026
-
Nov 28, 2025 Dec 30, 2025
-
Oct 03, 2025 Nov 06, 2025
-
Jul 29, 2025 Aug 26, 2025
-

Announced on	Ex-Date	Dividend%
Jul 01, 2021	Sep 08, 2021	25%
May 14, 2019	Aug 21, 2019	10%
Nov 09, 2017	Nov 20, 2017	10%
May 30, 2011	Sep 16, 2011	15%
May 31, 2010	Sep 23, 2010	20%

Announced on	Ex-Date
Oct 29, 2015	Feb 25, 2016
Split: Old FV10.0\| New FV:2.0

Announced on	Meeting on
Jun 01, 2026	Jun 30, 2026
-
Feb 10, 2026	Mar 14, 2026
-
Nov 28, 2025	Dec 30, 2025
-
Oct 03, 2025	Nov 06, 2025
-
Jul 29, 2025	Aug 26, 2025
-

About Sequent Scientific

Viyash Scientific Ltd., incorporated in the year 1985, is a Small Cap company (having a market cap of Rs 11,021.75 Crore) operating in Pharmaceuticals sector.

Industry

Pharma - Indian

Key Indices Listed On

BSE SmallCap, BSE Healthcare, BSE AllCap, BSE Next 250 Microcap, Nifty Smallcap 500

Address

3rd Floor, Srivalli�s Corporate,Plot No. 290, SYN 33 34P TO 39,Hyderabad, Telangana - 500033

Contact

investorrelations@sequent.in

http://www.sequent.in

Executive Leadership

Kamal K Sharma

Chairman & Ind.Director

Rajaram Narayanan

Managing Director & CEO

Vedprakash Ragate

Executive Director

Fabian Kausche

Non Executive Director

Auditors

S R B C & Co. LLP

FAQs about Sequent Scientific share

1. What is Sequent Scientific share price and what are the returns for Sequent Scientific share?
As on 10 Jun, 2026, 03:58 PM IST Sequent Scientific share price is down by 1.99% basis the previous closing price of Rs 251.8. Sequent Scientific share price is Rs 252.30. Return Performance of Sequent Scientific Shares:
- 1 Week: Sequent Scientific share price moved up by 1.73%
2. What are the returns for Sequent Scientific share?
Return Performance of Sequent Scientific Shares:
- 1 Week: Sequent Scientific share price moved up by 1.73%
3. What is the PE & PB ratio of Sequent Scientific?
The PE ratio of Sequent Scientific stands at 94.02, while the PB ratio is 3.61.
4. What is 52 week high/low of Sequent Scientific share price?
In last 52 weeks Sequent Scientific share had a high price of Rs 277.35 and low price of Rs 166.00
5. What's the market capitalization of Sequent Scientific?
Sequent Scientific share has a market capitalization of Rs 11,021.75 Cr. Within Pharmaceuticals sector, it's market cap rank is 43.

Top Gainers

As on 03:59 PM | 10 Jun 2026

Inox India

1,891.60

204.90 (12.15%)

Akums Drugs & Pharma

592.10

43.86 (8.00%)

Chambal Fertilisers

477.65

22.90 (5.04%)

Afcons Infrastru

330.05

14.56 (4.62%)

Concord Biotech Ltd.

1,330.70

58.50 (4.60%)

Top Losers

As on 03:59 PM | 10 Jun 2026

Oil India Ltd

427.35

-48.60 (-10.22%)

IFCI

71.83

-5.24 (-6.80%)

Manappuram Finance

288.25

-19.00 (-6.19%)

Jindal Saw

225.16

-14.66 (-6.11%)

NLC India

309.60

-18.15 (-5.54%)

Midcap stocks
Smallcap stocks
Largecap stocks
Sensex
Nifty
NSE
BSE
MCX Live

More from Markets

IPO
Stock market news
Budget 2022 Live Updates
Cryptocurrency
Currency converter
NSE holiday list

Trending in Markets

DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this site, you agree to the Terms of Service and Privacy Policy.

Sequent Scientific - Viyash Scientific Share Price

Key Metrics

Sequent Scientific share price insights

Sequent Scientific Share Price Returns

Sequent Scientific Share Recommendations

News & Analysis

Share Analysis

Unlock Stock Score, Analyst' Ratings & Recommendations

Financials

Share Price Forecast

Technicals

Peer Comparison

Shareholding Pattern

Mutual Funds Ownership

Quant Small Cap Direct-G

Quant Healthcare Direct-G

UTI Healthcare Direct-G

Sequent Scientific Top Searches

Corporate Actions

About Sequent Scientific

Executive Leadership

Auditors

FAQs about Sequent Scientific share

Top Gainers

Top Losers

Equity Quick Links

More from Markets

Trending in Markets

Browse Companies

Popular Categories

Hot on Web

In Case you missed it

Top Searched Companies

Latest News

PE Ratio(x)	92.89
EPS - TTM(₹)	2.74
MCap(₹ Cr.)	11,109.12
MCap Rank	43
PB Ratio(x)	3.61
Div Yield(%)	-
Face Value(₹)	2.00
52W High(₹)	277.05
52W Low(₹)	166.20
MCap/Sales	2.34
Beta(1 Month)	1.04
BV/Share(₹)	71.30

1 Day	-1.16%
1 Month	16.12%
3 Months	28.86%
1 Year	34.37%
3 Years	234.39%
5 Years	-6.8%

R1	-	Pivot -	S1	-
R2	-		S2	-
R3	-		S3	-